REGN vs. VHT

In the year-to-date period, REGN achieves a -15.16% return, which is significantly lower than VHT's -0.14% return. Over the past 10 years, REGN has underperformed VHT with an annualized return of 2.31%, while VHT has yielded a comparatively higher 7.94% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current REGN Sharpe Ratio is -1.11, which is lower than the VHT Sharpe Ratio of -0.03. The chart below compares the historical Sharpe Ratios of REGN and VHT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

REGN's dividend yield for the trailing twelve months is around 0.15%, less than VHT's 1.58% yield.

The maximum REGN drawdown since its inception was -91.81%, which is greater than VHT's maximum drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for REGN and VHT. For additional features, visit the drawdowns tool.

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 15.33% compared to Vanguard Health Care ETF (VHT) at 9.66%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than VHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.